Exhibition Recap | HWBIO Concludes Successful Participation at CCOS 2025!

The 29th Congress of the Chinese Ophthalmological Society (CCOS) was successfully held at the Hangzhou International Expo Center from September 4 to 7, 2025. As a highly influential academic event in ophthalmology, this year's congress, under the core theme of 'Building Consensus, Upholding Tradition and Driving Innovation,' brought together leading domestic and international ophthalmologists, clinicians, and representatives from industry-leading enterprises to explore cutting-edge advancements, technological innovations, and new clinical application pathways in ophthalmic medicine.

HWBIO had a strong presence at the event, showcasing its core product, the MeiboRevive™ Vectored Thermal Pulsation System. The booth became a focal point, earning extensive industry attention and high recognition through its innovative technology and immersive interactive zone.

Flagship Product Showcase: Pioneering New Directions in Dry Eye Treatment

The central highlight of the HWBIO booth was the MeiboRevive™ Vectored Thermal Pulsation System. Addressing key clinical challenges in dry eye treatment, the product utilizes advanced vectored thermal pulsation technology. It combines precise temperature control with pulsed massage to gently unclog meibomian glands and improve their function, alleviating dry eye symptoms at the source. Its non-invasive, comfortable treatment experience, efficient workflow, and flexible design adaptable to various clinical settings perfectly aligns with the modern ophthalmic principles of 'Precision Treatment and Patient Care.'

On-site, HWBIO's professional team conducted live product demonstrations and shared clinical cases, providing detailed explanations of the technology, clinical advantages, and application outcomes. Many ophthalmologists who observed the system up close noted that it overcomes the limitations of traditional dry eye therapies, offering a safer, more efficient clinical solution. They highlighted its particular suitability for the standardized treatment of chronic dry eye and Meibomian Gland Dysfunction (MGD), acknowledging its broad clinical application prospects.

Immersive Interactive Experience: Unlocking a New Exhibition Dimension

HWBIO specially set up a hands-on area for the MeiboRevive™ Vectored Thermal Pulsation System. With professional medical staff providing guidance, numerous attendees engaged in in-depth discussions with the team regarding product details and collaboration models after personal trial. These interactions created a vibrant atmosphere of professional inquiry. This immersive session not only allowed participants to personally verify the product's therapeutic effects but also built a bridge for deep integration between technology and clinical practice, further enhancing its market recognition.

Building Industry Consensus, Jointly Shaping a New Future for Eye Health

The conclusion of the 29th CCOS marks a new starting point for HWBIO's deep commitment to the eye health field. Moving forward, HWBIO remains committed to its innovative spirit and dedication to quality. Focused on repaying industry trust with superior products and services, the company will continue striving for excellence in eye health, ready to write many new chapters.